Search

STAAR Surgical Co

Suletud

SektorTervishoid

26.14 3.36

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

24.7

Max

26.2

Põhinäitajad

By Trading Economics

Sissetulek

5.2M

5.2M

Müük

36M

94M

Aktsiakasum

-0.23

Kasumimarginaal

5.567

Töötajad

921

EBITDA

19M

10M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+18.44% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

3. nov 2026

Turustatistika

By TradingEconomics

Turukapital

-135M

1.3B

Eelmine avamishind

22.78

Eelmine sulgemishind

26.14

Uudiste sentiment

By Acuity

23%

77%

79 / 340 Pingereas Healthcare

STAAR Surgical Co Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

14. aug 2026, 23:46 UTC

STAAR Surgical Co. shares declined after-market, reflecting broader market sentiment amid an unexpected drop in U.S. retail sales for July.

13. aug 2026, 20:02 UTC

Social Media
News

STAAR Surgical shares are lower after UBS cut its price target to $19.00, despite reporting strong second-quarter sales of $93.5 million.

12. aug 2026, 23:56 UTC

Social Media
News

STAAR Surgical shares are lower in after-market hours following an EPS miss, despite reporting second-quarter net sales of $93.5 million, a 111% increase.

11. aug 2026, 20:01 UTC

News

STAAR Surgical Co shares are lower today, reflecting broader market declines amid rising oil prices and inflation concerns ahead of U.S. inflation reports.

10. aug 2026, 20:02 UTC

Social Media
News

Broadwood has acquired over 1 million additional shares of STAAR Surgical, reflecting its long-term strategy, as the stock trades higher since Friday's close.

7. aug 2026, 22:56 UTC

Shares of STAAR Surgical Co. are trading higher in after-market hours, continuing a positive trend amid a supportive market backdrop following a decline in the unemployment rate.

6. aug 2026, 20:03 UTC

STAAR Surgical Co. shares are higher today, reflecting gains since Wednesday's close, though the stock remains below its 20-day moving average.

5. aug 2026, 20:02 UTC

STAAR Surgical shares are lower today, continuing a decline since Tuesday's close amid broader market volatility and external factors not directly impacting the company.

4. aug 2026, 19:51 UTC

STAAR Surgical Co shares are lower as Health Care Supplies sub-sector performance weighs on the stock. No specific news was identified for the decline.

3. aug 2026, 20:03 UTC

No specific news for STAAR Surgical as shares trade near unchanged. The broader market sees gains amid strong buying interest in technology stocks.

31. juuli 2026, 19:52 UTC

STAAR Surgical Co shares are lower amid weakness in the Health Care Supplies sub-sector. The stock has seen modest declines since Thursday's close.

30. juuli 2026, 19:29 UTC

STAAR Surgical Co. shares are lower today, reflecting a decline since Wednesday amid broader market volatility and rising Treasury yields.

29. juuli 2026, 22:11 UTC

STAAR Surgical Co shares are lower in after-market hours amid significant declines in the Health Care Supplies sub-sector, with no specific news identified.

28. juuli 2026, 18:56 UTC

News

STAAR Surgical Co shares declined after UBS initiated coverage with a Sell rating and set a price target of $20.00, closing at $22.95.

27. juuli 2026, 19:07 UTC

STAAR Surgical Co. shares are trading lower, continuing a recent downward trend amid broader market sentiment affected by declining crude oil prices.

22. juuli 2026, 18:11 UTC

News

Wedbush reiterated its OUTPERFORM rating on STAAR Surgical, maintaining a $40 price target, contributing to shares trading higher today.

21. juuli 2026, 16:56 UTC

Social Media

STAAR Surgical preannounces second-quarter revenue over $90 million, up from $44.3 million last year, as shares gain amid market volatility.

20. juuli 2026, 20:01 UTC

News

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.

Võrdlus sarnastega

Hinnamuutus

STAAR Surgical Co Prognoos

Hinnasiht

By TipRanks

18.44% tõus

12 kuu keskmine prognoos

Keskmine 30 USD  18.44%

Kõrge 40 USD

Madal 20 USD

Põhineb 7 Wall Streeti analüütiku instrumendi STAAR Surgical Co 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

7 ratings

2

Osta

4

Hoia

1

Müü

Sentiment

By Acuity

79 / 340 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat